Literature DB >> 32043307

Management of systemic sclerosis-associated interstitial lung disease in the current era.

Sogol Sara Amjadi1, David Roofeh2, Rajaie Namas3, Dinesh Khanna2.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32043307      PMCID： PMC7083212          DOI： 10.1111/1756-185X.13799

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN： 1756-1841            Impact factor:   2.454


× No keyword cloud information.
  22 in total

1.  Short-Term Pulmonary Function Trends Are Predictive of Mortality in Interstitial Lung Disease Associated With Systemic Sclerosis.

Authors:  Nicole S Goh; Rachel K Hoyles; Christopher P Denton; David M Hansell; Elisabetta A Renzoni; Toby M Maher; Andrew G Nicholson; Athol U Wells
Journal:  Arthritis Rheumatol       Date:  2017-07-18       Impact factor: 10.995

2.  Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease.

Authors:  Oliver Distler; Kristin B Highland; Martina Gahlemann; Arata Azuma; Aryeh Fischer; Maureen D Mayes; Ganesh Raghu; Wiebke Sauter; Mannaig Girard; Margarida Alves; Emmanuelle Clerisme-Beaty; Susanne Stowasser; Kay Tetzlaff; Masataka Kuwana; Toby M Maher
Journal:  N Engl J Med       Date:  2019-05-20       Impact factor: 91.245

3.  Intravenous cyclophosphamide vs rituximab for the treatment of early diffuse scleroderma lung disease: open label, randomized, controlled trial.

Authors:  Geetabali Sircar; Rudra Prosad Goswami; Dipankar Sircar; Alakendu Ghosh; Parasar Ghosh
Journal:  Rheumatology (Oxford)       Date:  2018-12-01       Impact factor: 7.580

Review 4.  Where are we going in the management of interstitial lung disease in patients with systemic sclerosis?

Authors:  Michele Iudici; Gianluca Moroncini; Paola Cipriani; Roberto Giacomelli; Armando Gabrielli; Gabriele Valentini
Journal:  Autoimmun Rev       Date:  2015-02-21       Impact factor: 9.754

5.  Tracking Impact of Interstitial Lung Disease in Systemic Sclerosis in a Complete Nationwide Cohort.

Authors:  Anna-Maria Hoffmann-Vold; Håvard Fretheim; Anne-Kristine Halse; Marit Seip; Helle Bitter; Marianne Wallenius; Torhild Garen; Anne Salberg; Cathrine Brunborg; Øyvind Midtvedt; May Brit Lund; Trond M Aaløkken; Øyvind Molberg
Journal:  Am J Respir Crit Care Med       Date:  2019-11-15       Impact factor: 21.405

6.  Interstitial lung disease in systemic sclerosis: a simple staging system.

Authors:  Nicole S L Goh; Sujal R Desai; Srihari Veeraraghavan; David M Hansell; Susan J Copley; Toby M Maher; Tamera J Corte; Clare R Sander; Jonathan Ratoff; Anand Devaraj; Gracijela Bozovic; Christopher P Denton; Carol M Black; Roland M du Bois; Athol U Wells
Journal:  Am J Respir Crit Care Med       Date:  2008-03-27       Impact factor: 21.405

Review 7.  Interstitial lung disease in systemic sclerosis.

Authors:  Athol U Wells; George A Margaritopoulos; Katerina M Antoniou; Chris Denton
Journal:  Semin Respir Crit Care Med       Date:  2014-03-25       Impact factor: 3.119

8.  Transitions to different patterns of interstitial lung disease in scleroderma with and without treatment.

Authors:  Hyun J Kim; Donald P Tashkin; David W Gjertson; Matthew S Brown; Eric Kleerup; Semin Chong; John A Belperio; Michael D Roth; Fereidoun Abtin; Robert Elashoff; Chi-Hong Tseng; Dinesh Khanna; Jonathan G Goldin
Journal:  Ann Rheum Dis       Date:  2016-01-12       Impact factor: 19.103

9.  Diagnosis of pulmonary hypertension.

Authors:  Adaani Frost; David Badesch; J Simon R Gibbs; Deepa Gopalan; Dinesh Khanna; Alessandra Manes; Ronald Oudiz; Toru Satoh; Fernando Torres; Adam Torbicki
Journal:  Eur Respir J       Date:  2019-01-24       Impact factor: 16.671

10.  Haematopoietic stem cell transplantation in systemic sclerosis.

Authors:  Ulrich A Walker; Lesley Ann Saketkoo; Oliver Distler
Journal:  RMD Open       Date:  2018-06-17
View more
  3 in total

1.  Outcome measurement instrument selection for lung physiology in systemic sclerosis associated interstitial lung disease: A systematic review using the OMERACT filter 2.1 process.

Authors:  David Roofeh; Shaney L Barratt; Athol U Wells; Leticia Kawano-Dourado; Donald Tashkin; Vibeke Strand; James Seibold; Susanna Proudman; Kevin K Brown; Paul F Dellaripa; Tracy Doyle; Thomas Leonard; Eric L Matteson; Chester V Oddis; Joshua J Solomon; Jeffrey A Sparks; Robert Vassallo; Lara Maxwell; Dorcas Beaton; Robin Christensen; Whitney Townsend; Dinesh Khanna
Journal:  Semin Arthritis Rheum       Date:  2021-08-20       Impact factor: 5.431

2.  Hospitalisations related to systemic sclerosis and the impact of interstitial lung disease. Analysis of patients hospitalised at the University of Michigan, USA.

Authors:  Shobana Sankar; Mirette Habib; Sara Jaafar; Vivek Nagaraja; David Roofeh; Amber Young; Suiyuan Huang; Dinesh Khanna
Journal:  Clin Exp Rheumatol       Date:  2021-03-10       Impact factor: 4.862

3.  Exome sequencing link mutation in RGPD4 with systemic sclerosis-associated interstitial lung disease and the low level of testosterone-an exploration study.

Authors:  Na Wang; Qian Zhang; Wei Sun; Xiaoyu Yang; Hui Huang; Zuojun Xu
Journal:  Front Oncol       Date:  2022-09-08       Impact factor: 5.738
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.